Publications by authors named "Abrar Aljohani"

7Publications

The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma.

Authors:
Chitra Joseph Mansour A Alsaleem Michael S Toss Yousif A Kariri Maryam Althobiti Sami Alsaeed Abrar I Aljohani Pavan L Narasimha Nigel P Mongan Andrew R Green Emad A Rakha

Cancers (Basel) 2020 Dec 30;13(1). Epub 2020 Dec 30.

School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham NG7 2RD, UK.

View Article and Find Full Text PDF
December 2020

Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.

Authors:
Khloud A Elsharawy Maryam Althobiti Omar J Mohammed Abrar I Aljohani Michael S Toss Andrew R Green Emad A Rakha

Breast Cancer Res Treat 2020 Nov 8. Epub 2020 Nov 8.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.

View Article and Find Full Text PDF
November 2020

The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer.

Authors:
Yousif A Kariri Mansour Alsaleem Chitra Joseph Sami Alsaeed Abrar Aljohani Sho Shiino Omar J Mohammed Michael S Toss Andrew R Green Emad A Rakha

Breast Cancer Res Treat 2020 Oct 19. Epub 2020 Oct 19.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.

View Article and Find Full Text PDF
October 2020

Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.

Authors:
Abrar I Aljohani Chitra Joseph Sasagu Kurozumi Omar J Mohammed Islam M Miligy Andrew R Green Emad A Rakha

Breast Cancer Res Treat 2020 Jun 29;181(3):541-551. Epub 2020 Apr 29.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK.

View Article and Find Full Text PDF
June 2020

Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.

Authors:
Sasagu Kurozumi Sami Alsaeed Nnamdi Orah Islam M Miligy Chitra Joseph Abrar Aljohani Michael S Toss Takaaki Fujii Ken Shirabe Andrew R Green Mohammed A Aleskandarany Emad A Rakha

Breast Cancer Res Treat 2020 Feb 9;179(3):557-564. Epub 2019 Nov 9.

Division of Cancer and Stem Cells, School of Medicine, Nottingham Breast Cancer Research Centre, University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF
February 2020

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.

Authors:
Abrar I Aljohani Michael S Toss Sasagu Kurozumi Chitra Joseph Mohammed A Aleskandarany Islam M Miligy Rokaya El Ansari Nigel P Mongan Ian O Ellis Andrew R Green Emad A Rakha

Breast Cancer Res Treat 2020 Jan 10;179(1):79-90. Epub 2019 Oct 10.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF
January 2020

A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.

Authors:
Sasagu Kurozumi Chitra Joseph Sultan Sonbul Sami Alsaeed Yousif Kariri Abrar Aljohani Sara Raafat Mansour Alsaleem Angela Ogden Simon J Johnston Mohammed A Aleskandarany Takaaki Fujii Ken Shirabe Carlos Caldas Ibraheem Ashankyty Leslie Dalton Ian O Ellis Christine Desmedt Andrew R Green Nigel P Mongan Emad A Rakha

Br J Cancer 2019 06 22;120(12):1129-1136. Epub 2019 May 22.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF
June 2019